Lithos Group (OTC:LITSF) Stock, Quote.Headers.trade-ideas

Lithos Group Ltd is a company having its application of Direct Lithium Extraction technology for economical, environmentally efficient, and sustainable lithium production. The Company has developed patented oil & gas wastewater solutions technology for DLE, called AcQUA. The modular technology can convert produced brine water into completely purified desalinated irrigation water and extract pure liquid commodity chemicals.

Large Cap

Latin America

Mid Cap

News

Penny Stocks

Small Cap

Management

Markets

Trading Ideas

ALTM

LITSF

Test Results Prove New Way to Pretreat Lithium Brine Works

Commodities

Source: Clive Maund 08/21/2024

Technical Analyst Clive Maund explains why he believes Lithos Group Ltd. is an Immediate Strong Buy.

Big Snapback Rally Expected Soon After Prolonged Accumulation

Events

MERCEDES BENZ GROUP AG by Mercedes Benz Group AG

MBGAF

Lithium Tech Co. Joins EV Research Group With Mercedes-Benz

Lithos Group Ltd

Coffee giant Starbucks Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) is in the middle of pumpkin spice latte season, which has turned into a huge sales and marketing boom for the company and comes with new CEO Brian Niccol taking the helm and <a href="https://www.benzinga.com/news/24/09/40809142/brian-niccol-outlines-vision-to-reconnect-starbucks-with-community-coffeehouse-roots-on-his-2nd-day">outlining plans for growth.</a>
What Happened: Starbucks first launched the pumpkin spice latte in August 2003. The beverage is now a staple for the company's menu each fall and a reason why Starbucks is one of the<a href="https://www.benzinga.com/news/earnings/24/07/40051434/starbucks-q3-earnings-revenue-miss-eps-in-line-comps-down-3-action-plan-is-beginning-to-work"> largest coffee chains in the world.</a>
The pumpkin spice latte followed the success of the peppermint mocha – the first seasonal beverage from Starbucks that saw blockbuster status.
"We started with a huge brainstorm list and filled the wall with ideas,"&nbsp;Peter Dukes, who led the espresso beverage team for Starbucks at the time, <a href="https://stories.starbucks.com/stories/2023/psl-turns-20-the-story-behind-starbucks-pumpkin-spice-latte/">recalls</a>. "We probably had at least a hundred ideas up on the wall."
Ideas for flavors like chocolate, caramel, orange, cinnamon, and, of course, pumpkin were displayed on the wall. Dukes recalls that pumpkin stood out to potential customers for its &#8220;uniqueness,&#8221; leading to its further development.
For three months, the Starbucks team worked to incorporate pumpkin flavor into a beverage.
The pumpkin spice latte was launched in the fall of 2003 with a test run at 100 stores in the Washington D.C. and Vancouver regions.
"Within the first week of the market test, we knew we had a winner. I remember calling store managers on the phone to see how the beverage was doing, and we could hear the excitement in their voices."
In 2004, the pumpkin spice latte went national and rolled out to stores across the U.S. and Canada. Facebook and Twitter helped popularize the drink in later years.
"With the arrival of social media, it just took off on a whole new level," Dukes said.
While many other restaurant and beverage companies have launched pumpkin spice products of their own, Starbucks remains one of the companies often thought of when a person hears the phrase.
Starbucks launched its lineup of pumpkin spice products, including several new items, on Aug. 22, 2024. This marked one of its earliest releases of the products, a date that to some represents the unofficial start of fall.
Foot traffic at Starbucks locations was up 24.1% on Thursday, Aug. 22 when the pumpkin spice latte returned, compared to the previous eight Thursdays, as reported by <a href="https://www.placer.ai/blog/pumpkin-spice-works-its-magic-once-again">Placer.ai.</a>
Traffic was also up by double-digit percentages in the following days after launch compared to their respective weekdays in the previous eight weeks.
"Starbucks' successful launch shows that even as consumers count their pennies, people are finding room in their budgets for sweet, cozy indulgences that don't break the bank," Placer.ai said.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent091124">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Investing $1,000 in Starbucks Stock:&nbsp;Investors who saw the test launch of this new Starbucks product and decided to buy Starbucks shares would have been pleasantly rewarded.
An investor could have purchased 132.45 shares of Starbucks on Oct. 10, 2003, based on a split adjusted price of $7.55.
The $1,000 investment would be worth $12,809.24 today, based on a price of $96.71 for Starbucks stock at the time of writing.
This represents a hypothetical return of 1,180.9%.
For comparison, the same $1,000 invested in the SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), which tracks the S&amp;P 500 Index, would be worth $5,278.27 today.
This represents a return of 427.8% over the same time period, which means an investment in Starbucks based off the pumpkin spice latte launch would have outperformed the broader stock market by a wide margin.
It truly may be pumpkin spice and everything nice for investors in Starbucks over the years.
"Nobody knew at the beginning what it would grow to be," Dukes said of the pumpkin spice latte. While he was talking of the Starbucks drink, the quote may apply to Starbucks stock as well.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40343728/starbucks-analysts-mixed-on-new-ceo-brian-niccol-who-led-cmg-stock-650-higher-in-6-">Starbucks Analysts Mixed On New CEO Brian Niccol, Who Led CMG Stock 650% Higher In 6 Years: &#8216;Starbucks Is No Chipotle&#8217;</a></li>
</ul>
This article was previously published by Benzinga and has been updated.

Education

Restaurants

SBUX

Starbucks Stock, Pumpkin Spice & Everything Nice: How Much $1,000 Invested In Coffee Giant When Pumpkin Spice Latte Was Introduced Would Be Worth Today

AVNW

Aviat Networks Files Notification Of Late Filing On Form 12b-25 With Respect To Annual Report On Form 10-K

The <a href="https://www.benzinga.com/topic/multidisciplinary-association-for-psychedelic-studies">Multidisciplinary Association for Psychedelic Studies (MAPS)</a> is pivoting its focus to state-level initiatives following the U.S. Food and Drug Administration's (FDA) recent <a href="https://www.benzinga.com/markets/cannabis/24/08/40300943/fda-rejects-mdma-for-ptsd-treatment-calls-for-more-research-on-psychedelic-therapy">denial of MDMA-assisted therapy</a>. As recently <a href="https://doubleblindmag.com/maps-future-of-mdma/">reported</a> by Double Blind, MAPS gathered a panel of experts to discuss what comes next after the federal setback. This shift signals a new chapter in MAPS&#8217; advocacy efforts, aiming to legalize psychedelic therapy through state-led ballot measures rather than waiting for federal approval.
<h3 class="wp-block-heading">Shifting Focus</h3>
The press conference followed the <a href="https://reaganudall.org/news-and-events/events/advancing-treatments-post-traumatic-stress-disorder">FDA and Reagan-Udall Foundation's public meeting on PTSD</a>, which included discussions on psychedelic therapy. Among the expert panel were well-known figures such as Dr. Bessel van der Kolk, author of The Body Keeps the Score; Michael Mithoefer, a principal investigator in MAPS' FDA trials; US Army veteran Darron Smith and Dave Rabin, host of The Psychedelic Report podcast. The discussion, moderated by MAPS director of communications Betty Aldworth, shed light on MAPS' next steps.
Aldworth expressed disappointment over the <a href="https://www.benzinga.com/markets/cannabis/24/08/40300943/fda-rejects-mdma-for-ptsd-treatment-calls-for-more-research-on-psychedelic-therapy">FDA&#8217;s decision</a> to deny Lykos Therapeutics&#8217; Novel Drug Application for MDMA-assisted therapy. "It's heartbreaking," Aldworth stated. However, she emphasized that the organization would now direct its attention to states like Colorado and Oregon, which have already passed laws legalizing psychedelic therapy. With Massachusetts <a href="https://www.benzinga.com/markets/cannabis/24/08/40447902/psychedelics-and-mental-health-fda-stalls-but-states-forge-ahead">voting on psychedelics legalization</a> in November, Aldworth noted, "Voters in those states&#8230; have decided it is time to move beyond the FDA process that is currently failing many patients living with PTSD."
<h3 class="wp-block-heading">Expert Voices On State-Led Approaches</h3>
Dr. van der Kolk echoed the sentiment, stating that "the next step is for the FDA to get overruled by state law." However, he also expressed cautious optimism regarding Massachusetts, warning that it might be too early to count on the bill's passage. Van der Kolk criticized the <a href="https://www.benzinga.com/topic/food-and-drug-administration">FDA</a> panel&#8217;s scientific understanding of psychedelics, saying, "The FDA panel was scientifically out to lunch."
Smith pointed out that efforts are also underway in North Carolina, where lawmakers have <a href="https://www.benzinga.com/markets/cannabis/23/05/32541361/psychedelics-reform-update-mis-task-force-ncs-5m-fund-cas-fed-follow-up-me-tables-proposal">advanced a bill to fund research</a> into psilocybin and MDMA. He also mentioned <a href="https://www.benzinga.com/markets/cannabis/24/03/37925833/utah-hospitals-will-soon-provide-psilocybin-and-mdma-therapy-for-mental-health-conditions">Utah's pilot program</a> that allows doctors in hospital settings to administer psychedelic treatments. "Given that the Mormon church runs Utah's legislature, that's very good," Smith said.
<h3 class="wp-block-heading">Broad Advocacy For Psychedelic Therapies</h3>
MAPS's shift aligns with statements made by other advocacy organizations. The Healing Advocacy Fund, a nonprofit championing state-regulated psychedelic programs, released a <a href="https://healingadvocacyfund.org/news/statement-on-fdas-failure-to-approve-mdma-assisted-therapy-for-post-traumatic-stress">statement</a> on August 9 calling for state-level leadership in the absence of federal action. "With an undeniable mental health crisis&#8230; we can't afford to wait for an ineffective federal bureaucracy to catch up. States must take the lead," the organization stated.
The panel closed with a reminder that underground <a href="https://www.benzinga.com/topic/mdma-assisted-therapy">MDMA therapy</a> is already occurring, with many individuals accessing the treatment informally. As Smith put it, "The cat's out of the bag," stressing the need for community-based efforts to expand access to these therapies, particularly for people of color. Van der Kolk agreed, emphasizing the importance of formalizing the process, saying, "We can only learn when it goes overground, and we can study and research it."
Cover image made with AI

Cannabis

Psychedelics

Health Care

Multidisciplinary Association For Psychedelic Studies Eyes State-Level Legalization After FDA Denial Of MDMA Therapy

Based on the new lease agreements already in place, MPT expects to receive aggregate annualized cash rental payments of approximately&nbsp;$160 million&nbsp;on this portfolio&#39;s approximate&nbsp;$2.0 billion&nbsp;lease base upon stabilization in the&nbsp;fourth quarter&nbsp;of 2026, including the impact of each lease&#39;s contractual minimum annual escalator.
This represents approximately&nbsp;95%&nbsp;of the cash rent Steward would have contractually owed for the same assets in the&nbsp;fourth quarter&nbsp;of 2026, based on minimum rent escalators. The weighted average initial term of the leases is approximately 18 years.

Medical Properties Trust Reaches Global Settlement Agreement Restoring Its Control Over Its Real Estate, Severs Its Relationship With Steward Health Care

YORVIPATH is a prodrug of parathyroid hormone (PTH [1-34]), administered once daily, designed to provide continuous exposure to released PTH over the 24-hour dosing period.
Hypoparathyroidism is a rare endocrine disease caused by insufficient levels of parathyroid hormone that impact multiple organs and affects an estimated 70,000 to 90,000 people in&nbsp;the United States.

ASND

Ascendis Pharma Says FDA Granted Orphan Drug Exclusivity To YORVIPATH For Treatment Of Hypoparathyroidism In Adults

Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) is losing its mojo in China&#8217;s crucial market as its domestic players gain ground. The uncertainty regarding the availability of the Apple Intelligence feature in the country is an additional downer.
The iPhone maker&#8217;s market share in China plunged to sixth place from third in the <a target="_blank" href="https://www.benzinga.com/markets/equities/24/07/39954971/apple-drops-from-3rd-to-6th-in-china-amid-intensifying-competition-huawei-shipments-surge-41-in-" rel="noreferrer noopener">second quarter of 2024</a>. According to Canalys, Apple had a market share of 14%, down by two basis points year-on-year.
Also Read: <a target="_blank" href="https://www.benzinga.com/government/24/09/40748185/chinas-markets-still-manage-to-get-nvidia-ai-chips-via-smuggling-report" rel="noreferrer noopener">China&#8217;s Markets Still Manage To Get Nvidia AI Chips Via Smuggling: Report</a>
China&#8217;s smartphone shipment grew 10% year-on-year to over 70 million units in the second quarter. Vivo emerged as the number one with a 19% market share by shipping <a href="https://www.canalys.com/newsroom/china-smartphone-market-Q2-2024" target="_blank" rel="noreferrer noopener">13.1 million units</a>, up by 15% year-on-year, driven by solid performance in offline channels and robust online sales during the Chinese e-commerce festival.
OPPO remained in second position with a 16% market share after shipping 11.3 million units. HONOR came third with a market share of 15%, backed by shipments of 10.7 million units, implying a 4% growth year-on-year. 
Huawei Technologies Co bagged the fourth position with a 15% market share supported by shipments of 10.6 million units, which grew by 41% year-on-year. Xiaomi Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/XIACF#OTC">XIACF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/XIACY#OTC">XIACY</a>) came fifth with a market share of 14%, backed by a 17% year-on-year shipment increase to 10 million units.
Canalys attributed the local brands&#8217; success to the early significant discounts and promotions backed by offline channel enhancements.
The local brands continue to tap the Chinese premium smartphone market by integrating generative artificial intelligence, and their deep collaboration with regional supply chains is a significant advantage, Canalys noted.
Canalys also flagged Apple&#8217;s struggle to maintain adequate inventory levels, keep retail prices in check, and maintain the margins of channel partners.
Huawei&#8217;s $2,800 Mate XT trifold phone <a target="_blank" href="https://www.benzinga.com/government/24/09/40793314/huawei-targets-iphones-premium-market-with-2-800-foldable-mate-xt-launch-report" rel="noreferrer noopener">launching on September 20</a> coincides with the release of the iPhone 16 models. Apple&#8217;s iPhone 16 Pro Max&nbsp;starts at $1,199, while the standard iPhone 16 is $799.
International Data Corporation (IDC)&nbsp;expects global smartphone shipments to <a target="_blank" href="https://www.benzinga.com/news/24/08/40600289/apples-market-share-poised-to-gain-genai-and-iphone-16-lead-the-way-idc" rel="noreferrer noopener">increase by 5.8%</a> to 1.23 billion units in 2024, marking a recovery with generative AI posing as a significant catalyst.
However, due to higher competition in China, Android growth is expected to beat Apple iOS. As per IDC, Apple&#8217;s success hinges on its capability to forge&nbsp;local AI partnerships&nbsp;in China.
Ivan Lam, senior analyst at Counterpoint Research <a target="_blank" href="https://www.scmp.com/tech/big-tech/article/3277043/iphone-16s-lack-apple-intelligence-china-leaves-market-open-rivals-huawei" rel="noreferrer noopener">told</a> SCMP that iPhone market share in the premium segment will likely decline as Huawei and other Chinese brands gain traction.
Apple has not yet revealed its plans for AI integration in China, which could place it at a disadvantage in the race to implement AI, SCMP cites Canalys analyst Lucas Zhong. However, Lam noted that pent-up demand for iPhone upgrades may still boost sales in China.
Price Action: AAPL stock closed at $222.66 on Wednesday.
image via Shutterstock

Emerging Markets

Tech

Media

AAPL

XIACF

XIACY

China Is Eating Apple's Lunch: Where Smartphone Maker Ranks Vs Asian Competitors

A group of cannabis companies filed an appeal challenging a <a href="https://www.benzinga.com/markets/cannabis/24/07/39586847/federal-court-dismisses-marijuana-companies-lawsuit-against-government-prohibition">federal court decision</a> to uphold cannabis prohibition under the U.S. Controlled Substances Act (CSA).
This appeal, led by renowned attorney David Boies, contests the dismissal of a <a href="https://www.benzinga.com/markets/cannabis/24/04/38281470/the-court-case-that-could-change-the-cannabis-industry-forever-and-how-it-affects-rescheduling">high profile lawsuit</a> aimed at blocking federal enforcement of cannabis prohibition against state-regulated businesses.
<h3 class="wp-block-heading">Procedure And Appeal</h3>
The original case, Canna Provisions, Inc. v. Merrick B. Garland, was brought by industry heavyweights including Verano Holdings Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VRNOF#OTC">VRNOF</a>), Canna Provisions and Wiseacre Farm among others. The plaintiffs argued that federal cannabis laws are outdated and unconstitutional, especially with 38 states now having legalized some form of marijuana. They contended that Congress&#8217;s original goal of eradicating marijuana through the CSA no longer applies in the modern regulatory landscape.
However, the U.S. District Court in Massachusetts dismissed the case, relying on a Supreme Court's 2005 decision, which upheld federal authority over intrastate marijuana regulation. Still, the court acknowledged the plaintiffs&#8217; compelling arguments. 
Next step is a response from the defendant in the case <a href="https://www.benzinga.com/topic/merrick-garland">Attorney General Merrick Garland</a>. His response will outline the government's position on the appeal and whether they believe the district court's dismissal was correct. After both sides present their arguments (the plaintiffs and the government), the U.S. Court of Appeals will decide whether to uphold the dismissal or overturn it.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40218753/high-times-hit-with-5m-class-action-lawsuit-over-unfulfilled-stock-deals">High Times Hit With $5M Class Action Lawsuit Over Unfulfilled Stock Deals</a>
<h3 class="wp-block-heading">Boies Argument Against Prohibition</h3>
On September 10, the plaintiffs formally <a href="https://s3.documentcloud.org/documents/25116548/2024-09-10-000-brief-tendered-by-appellants-canna-provisions-inc-gyasi.pdf?utm_source=www.cultivated.news&amp;utm_medium=newsletter&amp;utm_campaign=dea-suffers-its-first-post-chevron-blow-on-hemp&amp;_bhlid=26c269590737c5236a94fd0ca67abbbd34d726a4">appealed</a> the ruling in the First Circuit court. 
&#8220;Thirty-eight states have now legalized and regulate marijuana within their borders. The district court acknowledged that Plaintiffs-Appellants &#8216;alleged persuasive reasons for a reexamination of&#8217; the CSA but ruled it was bound by precedent.&#8221;, <a href="https://s3.documentcloud.org/documents/25116548/2024-09-10-000-brief-tendered-by-appellants-canna-provisions-inc-gyasi.pdf?utm_source=www.cultivated.news&amp;utm_medium=newsletter&amp;utm_campaign=dea-suffers-its-first-post-chevron-blow-on-hemp&amp;_bhlid=26c269590737c5236a94fd0ca67abbbd34d726a4">reads</a> the appellant&#8217;s presentation.
<a href="https://www.benzinga.com/markets/cannabis/24/04/38281470/the-court-case-that-could-change-the-cannabis-industry-forever-and-how-it-affects-rescheduling">Boies</a>, as head of Boies Schiller Flexner LLP, has represented clients such as the U.S. Department of Justice and Al Gore.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
In this case, Boies&#8217; main argument is that the federal government's enforcement of marijuana prohibition is no longer necessary or justified under the Commerce Clause.
The appeal also raises a Fifth Amendment claim, asserting that cannabis cultivation and use are "deeply rooted in the nation's history and tradition," making the CSA's prohibition unconstitutional. The plaintiffs&#8217; legal team further suggests that the landscape has changed dramatically since the Raich ruling, with bipartisan calls for marijuana reform growing.
Garland is expected to file a response by October 10, 2024. After the Court makes a decision and depending on the outcome, either side could appeal again, potentially bringing the case before the U.S. Supreme Court.
Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/07/39586847/federal-court-dismisses-marijuana-companies-lawsuit-against-government-prohibition">Federal Court Dismisses Marijuana Companies&#8217; Lawsuit Against Government Prohibition</a>
Cover: AI generated image

Government

Regulations

Politics

Legal

VRNOF

Cannabis Companies Fight Federal Court Dismissal On Prohibition Lawsuit, Heading To Next Legal Stop

KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) has outperformed the market over the past 10 years by 7.25% on an annualized basis producing an average annual return of 17.95%. Currently, KKR has a market capitalization of $104.98 billion. 
Buying $1000 In KKR: If an investor had bought $1000 of KKR stock 10 years ago, it would be worth $5,229.44 today based on a price of $118.29 for KKR at the time of writing.
<h3>KKR's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726090254_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In KKR 10 Years Ago Would Be Worth Today

NXP Semiconductors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) has outperformed the market over the past 10 years by 1.93% on an annualized basis producing an average annual return of 12.63%. Currently, NXP Semiconductors has a market capitalization of $58.74 billion. 
Buying $1000 In NXPI: If an investor had bought $1000 of NXPI stock 10 years ago, it would be worth $3,367.42 today based on a price of $230.59 for NXPI at the time of writing.
<h3>NXP Semiconductors's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726090249_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NXPI

Here's How Much You Would Have Made Owning NXP Semiconductors Stock In The Last 10 Years

Papa &amp; Barkley, a well-known <a href="http://benzingna.com/cannabis">cannabis</a> wellness brand in California, has merged into Mammoth Distribution, one of the state's leading distributors. The companies announced the merger Wednesday in a joint press release. This marks a significant consolidation within California's <a href="http://benzinga.com/topic/california-cannabis">cannabis industry</a>, promising a focus on quality, sustainability and expanded national reach.
<h3 class="wp-block-heading">Company Leaders Highlight Merger Benefits</h3>
Nik Patel, CEO and co-founder of Mammoth Distribution, highlighted the strategic benefits of the merger, stating, "Having Heavy Hitters, Papa &amp; Barkley, and Almora working together as one team allows us to make better products, cut our CO2 emissions by sharing trucks and deliveries, and strengthen our retail partnerships."
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.</li>
</ul>
"Our key performance indicator has always been ‘lives changed,' and joining the talented team at Mammoth Distribution will further that mission," said Adam Grossman, founder of Papa &amp; Barkley.
"We look forward to expanding Papa &amp; Barkley nationally, reaching more people who medically need our all-natural solventless cannabis products, made with the highest care and quality standards." 
Scott Gordon, a board member at Papa &amp; Barkley, expressed confidence in the decision. &#8220;After much consideration and discussions with potential partners, we chose Mammoth as the best home for Papa &amp; Barkley. Mammoth's strong commitment to its customers, employees and the quality of its products is exceptional.&#8221;
<h3 class="wp-block-heading">Mammoth Distribution Eyes Multi-State Growth</h3>
Currently operating in California and <a href="http://benzinga.com/topic/new-york-cannabis">New York</a>, Mammoth Distribution plans to extend its footprint across other states in the coming year and remains open to additional mergers that align with its cultural and quality standards.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/09/40804667/cannabis-hiring-platform-vangst-predicts-1m-full-time-marijuana-jobs-by-2029-announces-acquisiti">Cannabis Hiring Platform Vangst Predicts 1M Full-Time Marijuana Jobs By 2029, Announces Acquisition Of GreenForce Staffing Agency</a></li>
</ul>

California Cannabis Brands Papa & Barkley And Mammoth Distribution Announce Merger, Promising National Expansion

In addition, the Company intends to grant the underwriter a 30-day option to purchase up to an additional&nbsp;15%&nbsp;of the gross proceeds of its Class A common stock at the public offering price per share.
Owlet intends to use the net proceeds from the proposed public offering for general corporate purposes, capital expenditures, working capital and general and administrative expenses.

Offerings

OWLT

Owlet Intends To Offer And Sell Its Class A Common Stock In Public Offering; No Terms Disclosed

VSAT

Viasat Subsidiaries Upsizes And Prices Offering Of $1.975B Of Its 9.000% Senior Secured Notes Due 2029

CNEY

CN Energy Group Gets Nasdaq Notice That It Is Currently Not In Compliance With Certain Requirements Under Relevant Listing Rules

MSSA

Metal Sky Star Acquisition Reveals Receipt Of Additional Determination From Nasdaq On Delayed Filing And Public Holders Deficiencies

BHAT

Blue Hat Interactive Receives Nasdaq Notification Letter About Non-Compliance With Minimum Bid Price Requirement

WIIM

NTGR

NETGEAR shares are trading higher after the company disclosed a settlement agreement with TP-Link Systems and raised its Q3 revenue guidance.

In a bipartisan effort, two Florida state senators have come together to promote the Florida cannabis legalization initiative, known as <a href="https://drupal-cloudfront.benzinga.com/topic/amendment-3">Amendment 3</a> that will appear on the ballot in the <a href="https://www.benzinga.com/markets/cannabis/24/03/37992749/florida-supreme-court-shelves-cannabis-ballot-proposal-with-no-explanation-or-provisions-as-apri" target="_blank" rel="noreferrer noopener">November 2024 election</a>. Republican Sen. <a href="https://www.benzinga.com/markets/cannabis/24/08/40441169/florida-senator-proposes-outdoor-smoking-ban-if-weed-is-legalized-jacksonville-sheriff-dead-set-">Joe Gruters</a> and Democratic Sen. Shevrin Jones are featured in a new ad sponsored by the <a href="https://www.benzinga.com/markets/cannabis/24/04/38313915/cannabis-in-florida-the-bellamy-brothers-tell-trulieve-ceo-we-rolled-a-fat-one-when-legalization" target="_blank" rel="noreferrer noopener">Smart &amp; Safe Florida</a> campaign.
Gruters, a former chair of the Florida Republican Party, and Jones, a prominent Democratic senator, acknowledge that they "don't agree on much—hardly anything" and would each be voting for their respective party's presidential nominee, but legalizing marijuana is an issue they can both get behind.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Florida State Senator and Miami-Dade DEC Chairman <a href="https://twitter.com/ShevrinJones?ref_src=twsrc%5Etfw">@ShevrinJones</a> and State Senator and Former Republican Party of Florida Chair <a href="https://twitter.com/JoeGruters?ref_src=twsrc%5Etfw">@JoeGruters</a> may not agree on much, but they DO agree that safe, regulated marijuana is the right call for Florida. <a href="https://twitter.com/hashtag/YesOn3?src=hash&amp;ref_src=twsrc%5Etfw">#YesOn3</a> <a href="https://t.co/vRWJXzZhfu">pic.twitter.com/vRWJXzZhfu</a>
&mdash; Smart &amp; Safe Florida (@SmartandSafeFl) <a href="https://twitter.com/SmartandSafeFl/status/1833837189274206324?ref_src=twsrc%5Etfw">September 11, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Also:<a href="https://www.benzinga.com/markets/cannabis/24/09/40798916/desantis-vs-trump-over-florida-cannabis-legalization-guess-whos-winning"> DeSantis Vs. Trump Over Florida Cannabis Legalization: Guess Who&#8217;s Winning</a>
Gruters <a href="https://www.benzinga.com/markets/cannabis/24/07/40085870/ron-desantis-and-gop-stalwart-feud-over-cannabis-legalization-trump-floridas-top-cops-also-weigh" target="_blank" rel="noreferrer noopener">came out in favor</a>&nbsp;of cannabis legalization over the summer and Jones stressed the social justice aspects of the measure. He says legalizing cannabis would bring justice to marginalized communities that have been, still are, disproportionately affected by marijuana prohibition laws.
The amendment, if passed, would also channel tax revenue from legal marijuana sales into critical areas such as public education and law enforcement, a point both senators made. 
Meanwhile, Gov. <a href="https://www.benzinga.com/topic/ron-desantis">Ron DeSantis</a>, who <a href="https://www.benzinga.com/markets/cannabis/24/07/39827912/ron-desantis-blasts-floridas-cannabis-legalization-ballot-at-rnc-it-would-allow-80-joints-a-day-" target="_blank" rel="noreferrer noopener">vehemently opposes</a> the legalization measure <a href="https://www.benzinga.com/markets/cannabis/24/09/40798916/desantis-vs-trump-over-florida-cannabis-legalization-guess-whos-winning">said recently</a> that the cannabis legalization initiative in Florida is the result of &#8220;one weed company,&#8221; the medical marijuana company Trulieve Cannabis Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>), which he called a &#8220;de facto monopoly" and a "weed cartel."
Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.
<h2 class="wp-block-heading">Money To Be Made</h2>
At a roundtable in mid-June week in Tampa, Safe &amp; Smart<a href="https://www.benzinga.com/markets/cannabis/24/06/39346531/desantis-cant-get-past-the-odor-of-weed-to-smell-the-flowers-specifically-430m-annually-in-canna"> quoted economists</a> who estimate that legalizing marijuana could generate between $195 million and $431 million annually in sales tax revenue, providing a significant boost to the state's economy. 
Florida isn't alone in this potential windfall—other <a href="https://www.benzinga.com/markets/cannabis/24/05/38712820/legal-cannabis-states-raked-in-20b-since-2014-peaking-at-4b-in-2023-new-report-shows">states with legal marijuana </a>are raking in around $20 billion in tax revenue, according to legalization advocates. However, this appears insufficient to sway DeSantis.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/08/40383353/ron-desantis-slams-trulieves-alleged-canadian-ties-in-his-battle-against-cannabis-legalization">Ron DeSantis Slams Trulieve&#8217;s Alleged &#8216;Canadian&#8217; Ties In His Battle Against Cannabis Legalization</a></li>
</ul>
Image generated using artificial intelligence via Midjourney.

TCNNF

GOP And Democratic State Senators Back Florida's Cannabis Legalization Initiative In New Ad As Ballot Vote Looms

Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) has outperformed the market over the past 5 years by 8.13% on an annualized basis producing an average annual return of 21.13%. Currently, Spotify Technology has a market capitalization of $67.55 billion. 
Buying $1000 In SPOT: If an investor had bought $1000 of SPOT stock 5 years ago, it would be worth $2,626.67 today based on a price of $336.39 for SPOT at the time of writing.
<h3>Spotify Technology's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726088416_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SPOT

$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,600 Today

Murphy USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUSA#NYSE">MUSA</a>) has outperformed the market over the past 10 years by 14.43% on an annualized basis producing an average annual return of 25.14%. Currently, Murphy USA has a market capitalization of $10.72 billion. 
Buying $1000 In MUSA: If an investor had bought $1000 of MUSA stock 10 years ago, it would be worth $9,717.52 today based on a price of $522.90 for MUSA at the time of writing.
<h3>Murphy USA's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726088411_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MUSA

$1000 Invested In This Stock 10 Years Ago Would Be Worth $9,700 Today

Guidance

MIND

MIND Technology Expects To Achieve Revenue Growth, Positive Adjusted EBITDA And Greater Full Year Profitability In FY25

Press Releases

LiTHOS Announces Execution of Letter of Intent for Technology to Launch TiERRA™ Re-Injection Service

The 29th Annual EnerCom Denver - The Energy Investment Conference to Host The Energy Transition and Emerging Technology Session Featuring Start-Up Energy and Technology Companies

Presentation Times and Schedule for Participating Companies Now Posted on the Conference Website for 29th Annual EnerCom Denver - The Energy Investment Conference

Investor One-on-One Meeting Requests Open for 29th Annual EnerCom Denver - The Energy Investment Conference, to be held August 18-21, 2024 in Denver, Colorado

Earnings

LiTHOS Group Ltd. Strengthens Financial Position in FYE 2024

EnerCom's 29th Annual Energy Investment Conference is Set to be Held August 18-21, 2024 in Denver, Colorado

LiTHOS CEO Scott Taylor to Receive Outstanding Denver Technical Presentation Award and Present at EnerCom Denver® 2024

LiTHOS Announces Positive Results from AcQUA™ Technology Lithium Brine Tests with SQM on Salar de Atacama Brines

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Lithos Group

Lithos Group (LITSF) Forecast

Lithos Group (OTC:LITSF) Stock, Quote.Headers.trade-ideas